Kewaunee Scientific Corporation
NASDAQ:KEQUFurnishings, Fixtures & Appliances
-$0.41 today
- Market cap
- $100.35M
- Beta
- 0.69
- P/E (TTM)
- 9.6
- EPS (TTM)
- $3.87
Volume 0.00M
Average 0.00M
KEQU Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Kewaunee Scientific CorporationNASDAQ: KEQU
Capital Expenditures · Q3 FY2026 · quarter ended Jan 2026
Capital expenditures dips below year-ago levels
Q3 FY2026 capital expenditures of $668K (cash outflow) fell 3.0% year over year, behind the +34.1% change in trailing-twelve-month capital expenditures. Sequentially, it fell 57.5% from the prior quarter. Over 3 fiscal years it compounded at +4.3% a year.
Context
- Capital expenditures amounted to 0.9% of revenue in FY2025, down 1.2 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -3.0% toward the trailing-twelve-month pace of +34.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (2.17M) USD
- Year-over-year change
- +50.5%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-04-30 | (2.17M) | +50.5% |
| FY2024 | 2024-04-30 | (4.37M) | -5.4% |
| FY2023 | 2023-04-30 | (4.15M) | -117.4% |
| FY2022 | 2022-04-30 | (1.91M) | +20.4% |
| FY2021 | 2021-04-30 | (2.4M) | — |
Capital Expenditures vs competitors
How KEQU compares with its peers on the latest reported figures
- KEQU's LTM Jan 2026 capital expenditures of $3.53M is the 5th largest of the 8 companies compared; the peer median is $4.52M.
- Its year-over-year change of +34.1% is the 4th highest of 8, against a peer median of +12.9%.
- Capital expenditures amounts to 1.2% of revenue for KEQU, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2025 | $52.66M | +117.3% | +25.3% | 7.6% | |
| LTM Mar 2026 | $8.5M | -0.2% | -28.4% | 1.7% | |
| LTM Mar 2026 | $7.13M | +65.3% | -33.7% | 13.4% | |
| LTM Feb 2026 | $4.52M | +12.9% | -40.3% | 1.4% | |
| LTM Jan 2026 | $3.53M | +34.1% | +4.3% | 1.2% | |
| LTM May 2026 | $2.72M | -16.5% | -9.0% | 0.9% | |
| LTM Apr 2026 | $1.75M | +122.8% | +20.7% | 0.9% | |
| LTM Mar 2026 | $1.62M | -4.7% | -48.3% | 1.3% | |
| Peer median (excluding KEQU) | $4.52M | +12.9% | -28.4% | 1.4% | |
Competitors are the stored peer set for KEQU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Apr 2021 | FY2022 Apr 2022 | FY2023 Apr 2023 | FY2024 Apr 2024 | FY2025 Apr 2025 |
|---|---|---|---|---|---|
| Net Income | (3.61M) | (6M) | 1.36M | 18.75M | 11.58M |
| Depreciation & Amortization | 2.69M | 2.77M | 2.87M | 3.13M | 4.76M |
| Deferred Income Tax | 1.66M | 120K | 516K | (7.13M) | (2.2M) |
| Stock-Based Compensation | 634K | 729K | 886K | 1.03M | 1.44M |
| Change in Working Capital | (517K) | (5.59M) | (9.54M) | 3.21M | (2.02M) |
| Accounts Receivables | (6.09M) | (8.46M) | (4.95M) | 741K | (6.74M) |
| Inventory | (1.19M) | (7.28M) | 1.91M | 1.21M | 3.35M |
| Accounts Payables | 6.33M | 11.89M | (5.56M) | 0 | 583K |
| Other Working Capital | 429K | (1.74M) | (940K) | 1.25M | 1.37M |
| Other Non-Cash Items | 53K | 92K | 120K | 580K | 1.22M |
| Operating Cash Flow | 912K | (7.89M) | (3.79M) | 19.56M | 14.78M |
| Capital Expenditures | (2.4M) | (1.91M) | (4.15M) | (4.37M) | (2.17M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (28.74M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (2.4M) | (1.91M) | (4.15M) | (4.37M) | (30.9M) |
| Debt Repayment | 2.09M | 11.03M | 15.51M | (528K) | 10.77M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (2M) | (1.6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (108K) | 0 | (575K) | (488K) | (1.76M) |
| Financing Cash Flow | 1.98M | 11.03M | 14.93M | (3.01M) | 7.41M |
| Effect of Forex Changes | 19K | (75K) | (72K) | (54K) | (67K) |
| Net Change in Cash | 516K | 1.16M | 6.92M | 12.12M | (8.77M) |
| Free Cash Flow | (1.49M) | (9.79M) | (7.94M) | 15.19M | 12.62M |
Kewaunee Scientific Corporation
NASDAQ:KEQU
Intrinsic Alpha fair value
Locked
Current Price
$34.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.